Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surinabant for smoking cessation in nicotine-dependent adults
2006-005334-21Phase 2Completed
- Sponsor
- Sanofi
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of surinabant in nicotine dependence (4 arms), sponsored by Sanofi. Primary endpoint: Continuous abstinence from tobacco during the last four weeks of treatment. Started Nov 2006; status: completed.
02
Drugs
surinabant
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2006-005334-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005334-21.